<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>7 Laboratory assessment</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
    <style>
        .two-column-layout {
            display: flex;
            flex-wrap: wrap;
            gap: 2rem;
        }
        .column {
            flex: 1;
            min-width: 300px;
        }
        .abnormality-item {
            margin-bottom: 1.5rem;
        }
        .abnormality-item h4 {
            margin-bottom: 0.2rem;
            font-size: 1.1em;
            color: var(--primary-color);
        }
        .abnormality-item p {
            margin: 0;
            font-size: 0.95em;
        }
    </style>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="haematology-06-clinical-assessment.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 17.5%;"></div>
                        </div>
                       <span class="progress-text">Lecture 7 of 40</span>
                    </div>
                    <a href="haematology-08-benign-disorders-of-white-cells.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">7 Laboratory assessment</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <section id="routine-tests" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                        <span class="heading-text">Routine tests</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Full blood count (FBC) (see Table 3.1)</h3>
                        <p>Blood sample in sequestrene (ethylenediaminetetraacetate, EDTA) anticoagulant tested by an automated analyser. Analysers provide the following.</p>
                        <ul>
                            <li>Haemoglobin concentration, haematocrit, red cell count.</li>
                            <li>Red cell indices (mean cell volume, MCV; mean cell haemoglobin, MCH) (Table 7.1).</li>
                            <li>White cell count.</li>
                            <li>Differential white cell count (three-part: neutrophils, lymphocytes, monocytes; or five-part to include eosinophils and basophils). White cells are distinguished by use of biochemical staining reactions, light absorbance and scatter, and internal conductivity.</li>
                            <li>Platelet count and size.</li>
                            <li>Analysers increasingly provide automated reticulocyte counts, enumerate immature platelets ('platelet reticulocytes') and assess intra-erythrocyte haemoglobinization.</li>
                        </ul>

                        <h3 class="subsection-heading">Blood film</h3>
                        <p>Blood film is used to assess red cell size/shape; white cell appearance and differential; abnormal cells; platelet size and morphology; detection of parasites, e.g. malaria.</p>
                        <ul>
                            <li>The film may suggest a diagnosis, e.g. type of haemolytic anaemia, presence of malaria, leukaemia, myelodysplasia. Reticulocyte count (normal 0.5-3.5%) assesses bone marrow response to anaemia; raised in haemolysis, after haemorrhage, and in response to haematinic therapy.</li>
                        </ul>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 7.1 Classification of anaemia.</caption>
                                <tbody>
                                    <tr>
                                        <td><strong>Macrocytic (MCV > 98f)</strong></td>
                                        <td>Megaloblastic<br>&nbsp;&nbsp;&nbsp;&nbsp;Vitamin B12 or folate deficiency<br>Other<br>&nbsp;&nbsp;&nbsp;&nbsp;See Table 12.2</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Normocytic (MCV 78-98fl)</strong></td>
                                        <td>Most haemolytic anaemias<br>Secondary anaemias<br>Mixed cases</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Microcytic (MCV&lt;78fl; MCH usually also &lt;27pg/L)</strong></td>
                                        <td>Iron deficiency<br>Thalassaemia ($\alpha$ or $\beta$)<br>Other haemoglobin defects<br>Anaemia of chronic disorders (some cases)<br>Congenital sideroblastic anaemia (some cases)</td>
                                    </tr>
                                </tbody>
                                <tfoot>
                                    <tr>
                                        <td colspan="2" style="font-size: 0.9em; padding-top: 1em;">MCH, mean cell haemoglobin; MCV, mean cell volume.</td>
                                    </tr>
                                </tfoot>
                            </table>
                        </div>

                        <ul>
                            <li>Abnormalities of red cell shape and red cell inclusions are listed on page 29.</li>
                        </ul>
                    </div>
                </section>

                <section id="special-lab-tests" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-text">Special laboratory tests</span>
                    </h2>
                    <div class="content-card">
                        <p>Investigations of haemolytic anaemia, haemoglobin disorders, haematinic deficiency, coagulation disorders and malignant diseases are discussed in the relevant chapters.</p>
                    </div>
                </section>

                <section id="esr" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-text">Erythrocyte sedimentation rate (ESR)</span>
                    </h2>
                    <div class="content-card">
                        <p>This measures the rate of fall of a column of red cells in plasma in 1h. It is largely determined by plasma concentrations of proteins, especially fibrinogen and globulins. It is raised in anaemia. Normal range rises with age. A raised ESR is a non-specific indicator of an acute phase response and is of value in monitoring disease activity (e.g. rheumatoid arthritis). A raised ESR occurs in inflammatory disorders, infections, malignancy, myeloma, anaemia and pregnancy. The plasma viscosity gives comparable information and is increasingly favoured as it can be easily automated. C-reactive protein (CRP) is raised in an acute phase response and is valuable in monitoring this. Whole blood viscosity is also influenced by the cell counts, and is therefore raised when the red cell count (erythrocrit), white cells count (leucocrit) or platelet count is grossly raised.</p>
                    </div>
                </section>

                <section id="bone-marrow" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                        <span class="heading-text">Bone marrow aspiration and trephine biopsy</span>
                    </h2>
                    <div class="content-card">
                        <p>Bone marrow aspiration is from the posterior iliac crest or sternum; indications are listed in Table 7.2. Aspirated cells and particles of marrow are spread on slides, stained by Romanowsky's stain and for iron (Perls' stain; see Fig. 1.4). Specialized tests may also be performed (Table 7.3).</p>
                        
                        <div class="table-container">
                             <table class="content-table">
                                 <caption>Table 7.2 Indications for bone marrow aspiration (and trephine)*.</caption>
                                 <tbody>
                                     <tr>
                                         <td>Unexplained cytopenia*</td>
                                         <td>Anaemia, leucopenia, thrombocytopenia</td>
                                     </tr>
                                     <tr>
                                         <td>Suspected marrow infiltration*</td>
                                         <td>Leukaemia, myelodysplasia, lymphoma, myeloproliferative disease, myeloma, carcinoma, storage disorders</td>
                                     </tr>
                                     <tr>
                                         <td>Suspected infection</td>
                                         <td>Leishmaniasis, tuberculosis</td>
                                     </tr>
                                 </tbody>
                                 <tfoot>
                                     <tr>
                                         <td colspan="2" style="font-size: 0.9em; padding-top: 1em;">*Bone marrow trephine is also required for pancytopenia or suspected marrow infiltration.</td>
                                     </tr>
                                 </tfoot>
                             </table>
                        </div>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 7.3 Special tests on bone marrow cells.</caption>
                                <tbody>
                                    <tr>
                                        <td>1</td>
                                        <td><strong>Chromosomes</strong><br>Cytogenetics, e.g. diagnosis and classification of leukaemia, myelodysplasia<br>Fluorescent in situ hybridization (FISH)</td>
                                    </tr>
                                    <tr>
                                        <td>2</td>
                                        <td><strong>DNA analysis/polymerase chain reaction (PCR)</strong>, e.g. diagnosis and classification of leukaemia<br>Detection of residual malignant disease</td>
                                    </tr>
                                    <tr>
                                        <td>3</td>
                                        <td><strong>Immune phenotype analysis</strong><br>Diagnosis and classification of leukaemia, lymphoproliferative diseases<br>Detection of residual disease</td>
                                    </tr>
                                    <tr>
                                        <td>4</td>
                                        <td><strong>Microbiological cultures</strong>, e.g. tuberculosis</td>
                                    </tr>
                                    <tr>
                                        <td>5</td>
                                        <td><strong>Cytochemistry</strong>—diagnosis of acute leukaemias</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>

                <section id="sophisticated-tests" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                        <span class="heading-text">Sophisticated tests</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Flow cytometry</h3>
                        <p>Flow cytometry (Fig. 7.1) is an automated technique whereby a population of cells is incubated with specific monoclonal antibodies which are conjugated to a fluorochrome. The labelled cells are then passed in a fluid stream across a laser light source which allows quantitative analysis of antigen expression on the cell population. The technique is important in leukaemia diagnosis and assessment of residual malignant disease.</p>
                        
                        <figure>
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-026-1.jpg" alt="Fig. 7.1 Flow cytometry plot showing cell expression of CD23 versus IgM, used for immunophenotyping." class="content-image">
                            <figcaption>Fig. 7.1 Flow cytometry. Cells are simultaneously tested for expression of CD23 and IgM. The x and y scales indicate the number of cells detected expressing that antigen.</figcaption>
                        </figure>

                        <h3 class="subsection-heading">Chromosomal analysis</h3>
                        <p>Normal individuals have 46 chromosomes: 44 autosomes (22 from each parent) and two sex chromosomes ($46 \mathrm{XY} = \text{male}, 46 \mathrm{XX} = \text{female}$). Chromosomal analysis is made initially by special stains of cells in division. Loss or gain of whole chromosomes, chromosome breaks and loss, inversion or translocation of a part of a chromosome can be detected. Fluorescent in situ hybridization is a sensitive technique for detecting chromosome abnormalities (Fig. 7.2) which involves the use of a fluorescent DNA probe which hybridizes selectively to a particular chromosome segment, allowing sensitive detection of deletion, translocation and duplication of that segment.</p>
                        
                        <figure>
                            <div style="display: flex; gap: 1rem; justify-content: center; flex-wrap: wrap;">
                                <div style="text-align: center;">
                                    <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-026-2.jpg" alt="FISH analysis of a normal control showing two signals for chromosome 7." class="content-image" style="max-width: 300px;">
                                    <p>(a) Normal control</p>
                                </div>
                                <div style="text-align: center;">
                                    <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-026-3.jpg" alt="FISH analysis of a patient with myelodysplasia showing only one signal, indicating monosomy 7." class="content-image" style="max-width: 300px;">
                                    <p>(b) Patient with monosomy 7</p>
                                </div>
                            </div>
                            <figcaption style="text-align: center;">Fig. 7.2 Fluorescent in situ hybridization (FISH). Slides have been prepared from a cytogenetic preparation and hybridized with a fluorescent-labelled probe specific for chromosome 7. (a) Normal control showing two signals: (b) a patient with myelodysplasia who has monosomy 7.</figcaption>
                        </figure>
                    </div>
                </section>

                <section id="dna-abnormalities" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                        <span class="heading-text">DNA abnormalities</span>
                    </h2>
                    <div class="content-card">
                        <p>DNA abnormalities as a cause of haematological disease may be inherited or acquired (Table 7.4). Inherited haematological diseases are most commonly autosomal recessive, requiring an individual to inherit two mutant copies (alleles) of a gene (one from each parent) for expression of the disease (homozygotes). Carriers (heterozygotes) have one normal and one mutant allele and may express minor abnormalities. Autosomal dominant diseases are rarer, and require only one mutant allele for full expression of the disease. Sex-linked diseases arise if the mutant gene is on the X chromosome; males, having only one X chromosome, are affected whereas females are usually carriers. Acquired DNA abnormalities are frequently present in clones of malignant cell populations and serve as disease markers and clues to pathogenesis (see Chapter 19).</p>
                        
                        <div class="table-container">
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-027-1.jpg" alt="Table 7.4 Examples of inherited haematological diseases, categorized by inheritance pattern (Autosomal recessive, Autosomal dominant, Sex-linked)." class="content-image" style="width: 100%;">
                            <figcaption>Table 7.4 Examples of inherited haematological diseases.</figcaption>
                        </div>
                    </div>
                </section>

                <section id="molecular-techniques" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                        <span class="heading-text">Molecular techniques</span>
                    </h2>
                    <div class="content-card">
                        <p>These include:</p>
                        <ul>
                            <li>Southern blotting (Fig. 7.3) which allows assessment of deletion, rearrangement, inversion or duplication of DNA segments. Single base mutations will only be detected, however, if they alter the recognition sequence of a restriction enzyme.</li>
                        </ul>
                        
                        <figure>
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-027-2.jpg" alt="Fig. 7.3 Diagram of the Southern blot technique, showing DNA cleavage by restriction enzymes, separation by electrophoresis, transfer to a filter, and hybridization with a probe." class="content-image">
                            <figcaption>Fig. 7.3 Southern blot technique. Restriction enzymes are bacterial enzymes which recognize specific 3-6 nucleotide sequences (e.g. CCTCG) and cleave DNA whenever that sequence occurs. The fragments of DNA are separated by gel electrophoresis. DNA is then denatured to make it single-stranded and transferred by capillary action to a nylon filter. The filter is then incubated with a single stranded probe, which will hybridize to those DNA fragments with which there is base-pair homology. The Northern blot technique is a way of analysing RNA species by probe hybridization.</figcaption>
                        </figure>

                        <ul>
                            <li>Polymerase chain reaction (PCR) (Fig. 7.4) can be used to amplify a DNA segment which can then be sequenced or fractionated by size using gel electrophoresis. PCR can also be used to selectively amplify a particular sequence which may, for example, characterize a clone of malignant cells (minimal residual disease, see Chapter 19).</li>
                            <li>Gene expression is studied by analysing RNA extracted from fresh cells e.g. by gel electrophoresis (Northern blot). It can be semi-quantitated by using the enzyme reverse transcriptase to generate a DNA copy and then applying a modified PCR technique.</li>
                        </ul>

                        <figure>
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-027-3.jpg" alt="Fig. 7.4 Diagram illustrating the polymerase chain reaction (PCR) process, including denaturation, annealing of primers, and extension by TAQ polymerase to amplify a DNA segment." class="content-image">
                            <figcaption>Fig. 7.4 The polymerase chain reaction (PCR) can be used to amplify a DNA segment (typically $0.1-2 \mathrm{~kb}$). The template DNA is denatured and incubated with oligonucleotides (15-20 bp which hybridize specifically to sequences in template DNA and not anywhere else in the genome). The enzyme TAQ polymerase, in the presence of deoxynucleotides (dNTP), allows formation of a complete DNA chain complementary to the template sequence. This process is repeated 40 or so times. Modifications include amplifying a mRNA sequence into DNA and using nucleotides which only bind to a mutant and not a wild type DNA sequence so that only mutant sequences are amplified.</figcaption>
                        </figure>

                    </div>
                </section>
                
                <section id="haemostasis-disorders" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                        <span class="heading-text">Suspected disorders of haemostasis</span>
                    </h2>
                    <div class="content-card">
                         <p>Initial screening is with platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT) and thrombin time (TT). These simple tests of the coagulation pathway are performed by automated machines (coagulometers). If a defect of platelet function is suspected, test bleeding time and platelet function. If disseminated intravascular coagulation (DIC) is considered, measure fibrinogen level and test for fibrin degradation products. If a coagulation factor defect is suspected, assay specific clotting factors. A thrombophilia screen may be needed for patients with, or a family history of, thrombosis (see Chapter 32).</p>
                    </div>
                </section>

                <section id="red-cell-abnormalities" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                        <span class="heading-text">Red cell abnormalities</span>
                    </h2>
                    <div class="content-card two-column-layout">
                        <div class="column">
                            <div class="abnormality-item">
                                <h4>Normal</h4>
                            </div>
                            <div class="abnormality-item">
                                <h4>Macrocyte</h4>
                                <p><strong>Causes:</strong> Liver disease, alcoholism. Oval in megaloblastic anaemia.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Target cell</h4>
                                <p><strong>Causes:</strong> Iron deficiency, liver disease, haemoglobinopathies, post-splenectomy.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Stomatocyte</h4>
                                <p><strong>Causes:</strong> Liver disease, alcoholism.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Pencil cell</h4>
                                <p><strong>Causes:</strong> Iron deficiency.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Ecchinocyte</h4>
                                <p><strong>Causes:</strong> Liver disease, post-splenectomy.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Acanthocyte</h4>
                                <p><strong>Causes:</strong> Liver disease, abetalipoproteinaemia, renal failure.</p>
                            </div>
                             <div class="abnormality-item">
                                <h4>Sickle cell</h4>
                                <p><strong>Causes:</strong> Sickle cell anaemia.</p>
                            </div>
                             <div class="abnormality-item">
                                <h4>Microcyte</h4>
                                <p><strong>Causes:</strong> Iron deficiency, haemoglobinopathy.</p>
                            </div>
                        </div>
                        <div class="column">
                             <div class="abnormality-item">
                                <h4>Spherocyte</h4>
                                <p><strong>Causes:</strong> Hereditary spherocytosis autoimmune haemolytic anaemia, septicaemia.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Fragments</h4>
                                <p><strong>Causes:</strong> DIC, microangiopathy, HUS, TTP, burns, cardiac valves.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Elliptocyte</h4>
                                <p><strong>Causes:</strong> Hereditary elliptocytosis.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Tear drop poikilocyte</h4>
                                <p><strong>Causes:</strong> Myelofibrosis, extramedullary haemopoiesis.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Basket cell</h4>
                                <p><strong>Causes:</strong> Oxidant damage-e.g. G6PD deficiency, unstable haemoglobin.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Howell-Jolly body</h4>
                                <p><strong>Causes:</strong> Hyposplenism, post-splenectomy.</p>
                            </div>
                            <div class="abnormality-item">
                                <h4>Basophilic stippling</h4>
                                <p><strong>Causes:</strong> Haemoglobinopathy, lead poisoning, myelodysplasia, haemolytic anaemia.</p>
                            </div>
                             <div class="abnormality-item">
                                <h4>Malarial parasite</h4>
                                <p><strong>Causes:</strong> Malaria. Other intra-erythrocytic parasites include Bartonella bacilliformis, babesiosis.</p>
                            </div>
                             <div class="abnormality-item">
                                <h4>Siderotic granules (Pappenheimer bodies)</h4>
                                <p><strong>Causes:</strong> Disordered iron metabolism e.g. sideroblastic anaemia, post-splenectomy.</p>
                            </div>
                        </div>
                    </div>
                </section>

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="haematology-06-clinical-assessment.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 17.5%;"></div>
                        </div>
                       <span class="progress-text">Lecture 7 of 40</span>
                    </div>
                    <a href="haematology-08-benign-disorders-of-white-cells.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>